Transarterial chemoembolization outcomes for advanced hepatocellular carcinoma vs sorafenib and best supportive care in a sub-Saharan African cohort

doi:10.3748/wjg.v31.i46.112249

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 46

This Article

(53)

(44)

(0)

(979)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Dec 14, 2025; 31(46): 112249
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.112249

Full Size Figure Download Figure

Figure 1 Kaplan-Meier plot of the overall survival for the 71 patients who underwent transarterial chemoembolization as per Barcelona Clinic Liver Cancer stage B, C, and D disease. BCLC: Barcelona Clinic Liver Cancer.

Citation: Sobnach S, Sousa Silva KC, Abdel-Shafy EAR, Emmamally M, Spearman CW, Bernon M, Sonderup MW, Venter K, Kim I, Kotze U, Segobin R, Creamer DK, Cacciatore S, Zerbini LF, Jonas E. Transarterial chemoembolization outcomes for advanced hepatocellular carcinoma vs sorafenib and best supportive care in a sub-Saharan African cohort. World J Gastroenterol 2025; 31(46): 112249
URL: https://www.wjgnet.com/1007-9327/full/v31/i46/112249.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i46.112249

Sobnach S, Sousa Silva KC, Abdel-Shafy EAR, Emmamally M, Spearman CW, Bernon M, Sonderup MW, Venter K, Kim I, Kotze U, Segobin R, Creamer DK, Cacciatore S, Zerbini LF, Jonas E. Transarterial chemoembolization outcomes for advanced hepatocellular carcinoma vs sorafenib and best supportive care in a sub-Saharan African cohort. World J Gastroenterol 2025; 31(46): 112249 [PMID: 41479640 DOI: 10.3748/wjg.v31.i46.112249]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.